12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday’s after-market session. The market value…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Autolus Therapeutics (NASDAQ:AUTL) stock moved upwards by 15.0% to $2.3 during Tuesday’s after-market session. The market value…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers
FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Pulse Biosciences Announces FDA 510(k) Clearance For The Treatment Of Sebaceous Hyperplasia
Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced receipt of U.S. Food and
Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint
Bioelectric medicine company Pulse Biosciences Inc (NASDAQ:PLSE) announced a shift in focus to advance core NPS technology in the cardiac and oncology…
Maxim Group Downgrades Pulse Biosciences to Hold
Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
Strategic focus shifting to advance core NPS™ technology in cardiac and oncology sectors, activate additional executive leadership and reduce dermatologic footprint.
Former Chief Commercial Officer, Kevin Danahy,